Celularity Inc (CELU)
About Celularity Inc
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $26.6M
- Net income
- -$91.7M
- Total assets
- $107.3M
- Market cap
- $21.7M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $21.7M
- Shares outstanding
- 22.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 19, 2021
Celularity Inc (CELU) Stock Price
- Reported a net loss of $91.7M in FY2025.
- Trading 57% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Celularity Inc.
Write a review
News about Celularity Inc
News & sentiment via Polygon.io
Celularity Inc: frequently asked questions
Is Celularity Inc an American company?
Celularity Inc is a US-based company headquartered in Florham Park, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Celularity Inc headquartered?
Celularity Inc is headquartered in Florham Park, New Jersey, United States.
Is Celularity Inc publicly traded?
Yes — Celularity Inc is a publicly traded company. Its stock trades under the ticker symbol CELU on the NASDAQ.
What does Celularity Inc do?
Celularity Inc is an American Pharmaceuticals company in the Health & Beauty sector.